251 related articles for article (PubMed ID: 10077757)
1. Gastro-oesophageal reflux and Helicobacter pylori.
Pace F; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S289-93. PubMed ID: 10077757
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
[TBL] [Abstract][Full Text] [Related]
3. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE
Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
[TBL] [Abstract][Full Text] [Related]
4. Eradication of Helicobacter pylori might halt the progress to oesophageal adenocarcinoma in patients with gastro-oesophageal reflux disease and Barrett's oesophagus.
Kountouras J; Chatzopoulos D; Zavos C
Med Hypotheses; 2007; 68(5):1174-5. PubMed ID: 17196756
[No Abstract] [Full Text] [Related]
5. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
Rauws EA
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
Gisbert JP; Pajares JM; Losa C
Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.
Lord RV; Frommer DJ; Inder S; Tran D; Ward RL
Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939
[TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus and the presence of Helicobacter pylori.
Henihan RD; Stuart RC; Nolan N; Gorey TF; Hennessy TP; O'Morain CA
Am J Gastroenterol; 1998 Apr; 93(4):542-6. PubMed ID: 9576445
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and Barretts esophagus: a protective factor or a real cause?
Tomasello G; Giordano F; Mazzola M; Jurjus R; Jurjus A; Damiani P; Nobile S; Carini F; Leone A
J Biol Regul Homeost Agents; 2017; 31(1):9-15. PubMed ID: 28337865
[TBL] [Abstract][Full Text] [Related]
10. Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?
Lundell L
Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S23-7. PubMed ID: 11430505
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
[TBL] [Abstract][Full Text] [Related]
12. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
[TBL] [Abstract][Full Text] [Related]
13. Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.
Bergman MP; Klinkenberg-Knol EC; Faller G; Aar A; Lakhai W; Vandenbroucke-Grauls CM; Kuipers EJ; Appelmelk BJ
Aliment Pharmacol Ther; 2005 Apr; 21(8):977-83. PubMed ID: 15813833
[TBL] [Abstract][Full Text] [Related]
14. [Barrett's esophagus and Helicobacter pylori].
Sakata H; Fujimoto K
Nihon Rinsho; 2005 Aug; 63(8):1383-6. PubMed ID: 16101226
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection and the risk of adenocarcinoma of the esophagus.
Celiński K; Słomka M; Kasztelan-Szczerbińska B; Madro A; Cichoz-Lach H; Kurzeja A
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):424-7. PubMed ID: 16146024
[TBL] [Abstract][Full Text] [Related]
16. [Gastroesophageal reflux disease and Helicobacter pylori infection].
Naumovski-Mihalić S; Sabarić B; Filipec T; Tićak M; Prskalo M; Skurla B; Papa B; Dominis M; Katicić M
Lijec Vjesn; 2002 Sep; 124 Suppl 1():52-6. PubMed ID: 12592818
[TBL] [Abstract][Full Text] [Related]
17. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
Delaney B; McColl K
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
[TBL] [Abstract][Full Text] [Related]
18. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of gastro-oesophageal reflux disease: what role do Helicobacter pylori and host genetic factors play?
Chourasia D; Ghoshal UC
Trop Gastroenterol; 2008; 29(1):13-9. PubMed ID: 18564661
[TBL] [Abstract][Full Text] [Related]
20. Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan.
Haruma K
Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():40-4. PubMed ID: 15575872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
